This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Hyperion Therapeutics Inc (HPTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 74.23M 49.85M 7.02M
Receivables 4.42M 0.00 0.00
Inventories 3.51M 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 111.61M 51.01M 8.06M
Property, Plant & Equipment, Gross 1.20M 49.00K 19.00K
Accumulated Depreciation & Depletion 264.00K 0.00 0.00
Property, Plant & Equipment, Net 936.00K 49.00K 19.00K
Intangibles 13.44M 0.00 0.00
Other Non-Current Assets 16.53M 147.00K 59.00K
Total Non-Current Assets 30.91M 196.00K 78.00K
Liabilities & Shareholder Equity
Total Assets 142.52M 51.20M 8.14M
Accounts Payable 3.45M 2.18M 1.89M
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 326.00K 0.00 737.00K
Total Current Liabilities 20.13M 9.06M 29.35M
Long Term Debt 2.62M 7.75M 0.00
Deferred Income Taxes 81.00K 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 2.57M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 2.70M 7.75M 60.90M
Total Liabilities 22.83M 16.82M 90.25M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 119.69M 34.39M -82.10M
Common Par 2.00K 2.00K 0.00
Additional Paid In Capital 242.11M 173.38M 24.63M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -122.37M -139.00M -106.73M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -55.00K 0.00 0.00
Total Capitalization 122.31M 42.14M -82.10M
Total Equity 119.69M 34.39M -82.10M
Total Liabilities & Stock Equity 142.52M 51.20M 8.14M
Total Common Shares Outstanding 20.14M 16.65M 15.84M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 19.42M 7.26M 8.77M
Diluted Weighted Shares Outstanding 20.73M 7.26M 8.77M
Number of Employees 54 22 NA
Number of Part-Time Employees 0 0 NA

HPTX Hyperion Therapeutics Inc

Analysts Ratings for HPTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 4 3 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

HPTX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs